These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 6679629)
21. The role of l-thyroxine and hepatic reductase activity in isoniazid-induced hepatotoxicity in rabbits. Sarich TC; Adams SP; Wright JM Pharmacol Res; 1998 Sep; 38(3):199-207. PubMed ID: 9782070 [TBL] [Abstract][Full Text] [Related]
22. Isoniazid hepatoxicity: the relationship between covalent binding and metabolism in vivo. Timbrell JA; Mitchell JR; Snodgrass WR; Nelson SD J Pharmacol Exp Ther; 1980 May; 213(2):364-9. PubMed ID: 6767840 [TBL] [Abstract][Full Text] [Related]
23. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro. Timbrell JA; Wright JM Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727 [TBL] [Abstract][Full Text] [Related]
24. Participation of P450-dependent oxidation of isoniazid in isonicotinic acid formation in rat liver. Ono Y; Wu X; Noda A; Noda H; Yoshitani T Biol Pharm Bull; 1998 Apr; 21(4):421-5. PubMed ID: 9586587 [TBL] [Abstract][Full Text] [Related]
25. Isoniazid-induced hepatic steatosis in rabbits: an explanation for susceptibility and its antagonism by pyridoxine hydrochloride. Whitehouse LW; Tryphonas L; Paul CJ; Solomonraj G; Thomas BH; Wong LT Can J Physiol Pharmacol; 1983 May; 61(5):478-87. PubMed ID: 6883201 [TBL] [Abstract][Full Text] [Related]
26. Elevation of brain GABA content by chronic low-dosage administration of hydrazine, a metabolite of isoniazid. Perry TL; Kish SJ; Hansen S; Wright JM; Wall RA; Dunn WL; Bellward GD J Neurochem; 1981 Jul; 37(1):32-9. PubMed ID: 7252511 [TBL] [Abstract][Full Text] [Related]
27. Comparative bioequivalence study of rifampicin and isoniazid combinations in healthy volunteers. Padgaonkar KA; Revankar SN; Bhatt AD; Vaz JA; Desai ND; D'Sa S; Shah V; Gandewar K Int J Tuberc Lung Dis; 1999 Jul; 3(7):627-31. PubMed ID: 10423226 [TBL] [Abstract][Full Text] [Related]
28. Role of CYP3A in isoniazid metabolism in vivo. Liu K; Li F; Lu J; Gao Z; Klaassen CD; Ma X Drug Metab Pharmacokinet; 2014; 29(2):219-22. PubMed ID: 24172716 [TBL] [Abstract][Full Text] [Related]
29. A model of isoniazid-induced hepatotoxicity in rabbits. Sarich TC; Zhou T; Adams SP; Bain AI; Wall RA; Wright JM J Pharmacol Toxicol Methods; 1995 Oct; 34(2):109-16. PubMed ID: 8563032 [TBL] [Abstract][Full Text] [Related]
30. Neurotoxicity of isoniazid and its metabolites in cultures of mouse dorsal root ganglion neurons and hybrid neuronal cell line. Sanfeliu C; Wright JM; Kim SU Neurotoxicology; 1999 Dec; 20(6):935-44. PubMed ID: 10693974 [TBL] [Abstract][Full Text] [Related]
31. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Yue J; Peng RX; Yang J; Kong R; Liu J Acta Pharmacol Sin; 2004 May; 25(5):699-704. PubMed ID: 15132840 [TBL] [Abstract][Full Text] [Related]
32. Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity. Tostmann A; Boeree MJ; Peters WH; Roelofs HM; Aarnoutse RE; van der Ven AJ; Dekhuijzen PN Int J Antimicrob Agents; 2008 Jun; 31(6):577-80. PubMed ID: 18358703 [TBL] [Abstract][Full Text] [Related]
33. Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats. Metushi IG; Nakagawa T; Uetrecht J Chem Res Toxicol; 2012 Nov; 25(11):2567-76. PubMed ID: 23016703 [TBL] [Abstract][Full Text] [Related]
34. Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man. Jenner PJ; Ellard GA Tubercle; 1989 Jun; 70(2):93-101. PubMed ID: 2617692 [TBL] [Abstract][Full Text] [Related]
35. Comprehensive assay for pyrazinamide, rifampicin and isoniazid with its hydrazine metabolites in human plasma by column liquid chromatography. Walubo A; Smith P; Folb PI J Chromatogr B Biomed Appl; 1994 Aug; 658(2):391-6. PubMed ID: 7820269 [TBL] [Abstract][Full Text] [Related]
36. Tissue distribution of isoniazid and its metabolites in rats. Kaneo Y; Kubo H; Tabata T; Matsuyama K; Noda A; Iguchi S J Pharmacobiodyn; 1981 Aug; 4(8):590-5. PubMed ID: 7299622 [TBL] [Abstract][Full Text] [Related]
37. Role of hydrazine in isoniazid-induced hepatotoxicity in a hepatocyte inflammation model. Tafazoli S; Mashregi M; O'Brien PJ Toxicol Appl Pharmacol; 2008 May; 229(1):94-101. PubMed ID: 18295292 [TBL] [Abstract][Full Text] [Related]
38. Effect of isoniazid administration on selected rat and mouse hepatic microsomal mixed-function oxidases and in vitro [14C]acetylhydrazine-derived covalent binding. Powell-Jackson PR; Tredger JM; Smith HM; Davis M; Williams R Biochem Pharmacol; 1982 Dec; 31(24):4031-4. PubMed ID: 7159479 [TBL] [Abstract][Full Text] [Related]
39. Induction of Heme oxygenase 1 protects hepatocytes from Isoniazid – Rifampicin induced cell death: an in vitro study. Bishnu D; Santra S; Dhali GK; Chowdhury A; Santra A Trop Gastroenterol; 2016; 37(1):27-36. PubMed ID: 29668174 [TBL] [Abstract][Full Text] [Related]
40. The role of oxygen free radicals in isoniazid-induced hepatotoxicity. Walubo A; Smith P; Folb PI Methods Find Exp Clin Pharmacol; 1998 Oct; 20(8):649-55. PubMed ID: 9922980 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]